Bruno M. L. Giannetti
Geschäftsführer bei Pharming Intellectual Property BV
Aktive Positionen von Bruno M. L. Giannetti
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Pharming Intellectual Property BV
Pharming Intellectual Property BV Trucks/Construction/Farm MachineryProducer Manufacturing Part of Pharming Group NV, Pharming Intellectual Property BV manufactures milking equipment. The company is based in Leiden, Netherlands. The CEO of the Dutch company is Sijmen de Vries. | Geschäftsführer | - | - |
Karriereverlauf von Bruno M. L. Giannetti
Ehemalige bekannte Positionen von Bruno M. L. Giannetti
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CRM Pharmaberatung GmbH | Gründer | 21.06.2010 | 31.10.2013 |
Präsident | 21.06.2010 | 31.10.2013 | |
Immuno AG | Vertrieb & Marketing | - | 09.12.2010 |
CRM clinical trials GmbH
CRM clinical trials GmbH Miscellaneous Commercial ServicesCommercial Services Part of hVIVO PLC, CRM clinical trials GmbH is a German company that provides clinical research and clinical trials management services. The company is based in Rheinbach, Germany. The company was founded by Bruno M. L. Giannetti. CRM clinical trials was acquired by Venn Life Sciences Holdings Plc on January 13, 2014 for $0.83 million. | Gründer | - | - |
Präsident | - | - | |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Vorstandsvorsitzender | 01.01.2006 | - |
Madaus GmbH
Madaus GmbH Pharmaceuticals: MajorHealth Technology MADAUS GmbH manufactures pharmaceutical products. It provides medicines of plant origin together with products for 'Natural Prevention'. The firm offers products to treat the fundamental causes of disease, not merely the symptoms, and thereby to prevent diseases from occurring or at least from becoming chronic. The company was founded in 1919 by Gerhard Madaus, Friedemund Madaus and Hans Madaus and is headquartered in Cologne, Germany. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Verigen AG
Verigen AG Miscellaneous Commercial ServicesCommercial Services Verigen specializes in tissue engineering. Its cartilage repair technology involves harvesting knee cartilage cells that are cultivated in a laboratory before being transplanted into the knee. The operation is invasive and shorter than conventional treatment, with concomitant cost savings and outcomes | Vorstandsvorsitzender | - | - |
Präsident | - | - | |
PHARMING GROUP N.V. | Geschäftsführer | 01.12.2006 | 01.01.2019 |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.2019 | - |
Ausbildung von Bruno M. L. Giannetti
University of Bonn | Doctorate Degree |
Statistik
International
Deutschland | 6 |
Niederlande | 4 |
Österreich | 2 |
Operativ
President | 3 |
Chief Operating Officer | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Sektoral
Health Technology | 4 |
Commercial Services | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PHARMING GROUP N.V. | Health Technology |
Private Unternehmen | 7 |
---|---|
Madaus GmbH
Madaus GmbH Pharmaceuticals: MajorHealth Technology MADAUS GmbH manufactures pharmaceutical products. It provides medicines of plant origin together with products for 'Natural Prevention'. The firm offers products to treat the fundamental causes of disease, not merely the symptoms, and thereby to prevent diseases from occurring or at least from becoming chronic. The company was founded in 1919 by Gerhard Madaus, Friedemund Madaus and Hans Madaus and is headquartered in Cologne, Germany. | Health Technology |
Verigen AG
Verigen AG Miscellaneous Commercial ServicesCommercial Services Verigen specializes in tissue engineering. Its cartilage repair technology involves harvesting knee cartilage cells that are cultivated in a laboratory before being transplanted into the knee. The operation is invasive and shorter than conventional treatment, with concomitant cost savings and outcomes | Commercial Services |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Health Technology |
Immuno AG | |
CRM Pharmaberatung GmbH | |
CRM clinical trials GmbH
CRM clinical trials GmbH Miscellaneous Commercial ServicesCommercial Services Part of hVIVO PLC, CRM clinical trials GmbH is a German company that provides clinical research and clinical trials management services. The company is based in Rheinbach, Germany. The company was founded by Bruno M. L. Giannetti. CRM clinical trials was acquired by Venn Life Sciences Holdings Plc on January 13, 2014 for $0.83 million. | Commercial Services |
Pharming Intellectual Property BV
Pharming Intellectual Property BV Trucks/Construction/Farm MachineryProducer Manufacturing Part of Pharming Group NV, Pharming Intellectual Property BV manufactures milking equipment. The company is based in Leiden, Netherlands. The CEO of the Dutch company is Sijmen de Vries. | Producer Manufacturing |
- Börse
- Insiders
- Bruno M. L. Giannetti
- Erfahrung